- Home
- GALT vs GOODN Comparison
GALT vs GOODN Comparison
Compare GALT & GOODN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GALT | GOODN |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | 72 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.2M | N/A |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | GALT | GOODN |
|---|---|---|
| Price | $2.71 | $22.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 330.6K | 2.4K |
| Earning Date | 03-31-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.15 | $20.51 |
| 52 Week High | $7.13 | $24.35 |
Technical Indicators
Market Signals| Indicator | GALT | GOODN |
|---|---|---|
| Relative Strength Index (RSI) | 39.14 | 38.25 |
| Support Level | $2.57 | $22.27 |
| Resistance Level | $3.37 | $22.69 |
| Average True Range (ATR) | 0.25 | 0.08 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 8.33 | 33.33 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About GOODN Gladstone Commercial Corporation
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.